BioSynaptica
Manufacturing · Argentina · 1-10 Employees
View Company Info for Free
Overview
Headquarters
ArgentinaPhone Number
+54 93424625309Website
www.biosynaptica.comRevenue
<$5 MillionIndustry
About BioSynaptica
BioSynaptica Org Chart
Is BioSynaptica your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if BioSynaptica had a recent Job posting/layoffs
Earning: See what the market has to say on BioSynaptica recently announced quarterly report
Product Launch: Get notified when BioSynaptica launches new products
Check if BioSynaptica has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at BioSynaptica
BioSynaptica, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once BioSynaptica has new funding data
Check out if BioSynaptica is spiking on competitors!
Website visits: Recent activity has been detected on your website
Recommended Actions
Find VP level buyers at BioSynaptica
Find 2 more new buyers
Company Profile Activity
Activity Insights
BioSynaptica is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
BioSynaptica is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about BioSynaptica.
BioSynaptica Tech Stack
A closer look at the technologies used by BioSynaptica
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding BioSynaptica
BioSynaptica is a startup focused on developing innovative biopharmaceuticals for the treatment of neurodegenerative diseases. Their primary product is a modified form of human erythropoietin (hEPO) that aims to provide neuroprotective and neuroplastic benefits without the unwanted erythropoietic effects. The company targets individuals suffering f... Read More